A randomized study of the value of dosimetry in the use of 131I for ablation of post. operative thyroid remnants.

被引：0
|
作者：
Silberstein, EB [1 ]
机构：
[1] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2001年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1358.1
引用
收藏
页码：350P / 350P
页数：1
相关论文
共 50 条
  • [41] Negative serum thyroglobulin in low stage thyroid carcinoma patients with thyroid remnants in the post-ablation therapy I-131 whole body scans: a casuistic analysis
    Macedo, R.
    Correia, J.
    Costa, G.
    Pedroso-Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S180 - S180
  • [42] Fixed dose versus dosimetry based approach in radioiodine (131I) therapy of autonomously functioning thyroid nodule (AFTN): A randomized controlled trial in the Indian population
    Sharma, Shekhar
    Damle, Nishikant
    Singla, Suhas
    Bal, Chandrasekhar
    Hari, Smriti
    Ballal, Sanjana
    Yadav, Madhav
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [43] Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after 131I ablation therapy in patients with differentiated thyroid cancer
    Toubeau, M
    Touzery, C
    Arveux, P
    Chaplain, G
    Vaillant, G
    Berriolo, A
    Riedinger, JM
    Boichot, C
    Cochet, A
    Brunotte, F
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (06) : 988 - 994
  • [44] Significance of Salivary Gland Radioiodine Retention on Post-ablation 131I Scintigraphy as a Predictor of Salivary Gland Dysfunction in Patients with Differentiated Thyroid Carcinoma
    Jo K.S.
    An Y.-S.
    Lee S.J.
    Soh E.-Y.
    Lee J.
    Chung Y.-S.
    Kim D.J.
    Yoon S.-H.
    Lee D.H.
    Yoon J.-K.
    Nuclear Medicine and Molecular Imaging, 2014, 48 (3) : 203 - 211
  • [45] A comparison study of remnant thyroid gland using salivary scintigraphy with post-ablation I-131 scan
    Jo, Kwanhyeong
    Hwang, Sang Hyun
    Jeong, Yong Hyu
    Cho, Arthur
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [46] Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software
    Kolbert, Katherine S.
    Pentlow, Keith S.
    Pearson, Joel R.
    Sheikh, Arif
    Finn, Ronald D.
    Humm, John L.
    Larson, Steven M.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (01) : 143 - 149
  • [47] Lymph Node Metastases Identified at the Post-Ablation 131I SPECT/CT Scan Is a Prognostic Factor of Intermediate-Risk Papillary Thyroid Cancer
    Jia, Xi
    Wang, Yuanbo
    Yang, Lulu
    Fan, Kun
    Tao, Runyi
    Liu, Hui
    Yao, Xiaobao
    Yang, Aimin
    Zhang, Guangjian
    Gao, Rui
    DIAGNOSTICS, 2022, 12 (05)
  • [48] Deep learning enables automated localization of the metastatic lymph node for thyroid cancer on 131I post-ablation whole-body planar scans
    MuthuSubash Kavitha
    Chang-Hee Lee
    KattakkaliSubhashdas Shibudas
    Takio Kurita
    Byeong-Cheol Ahn
    Scientific Reports, 10
  • [49] Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma
    Cherk, Martin H.
    Kalff, Victor
    Yap, Kenneth S. K.
    Bailey, Michael
    Topliss, Duncan
    Kelly, Michael J.
    CLINICAL ENDOCRINOLOGY, 2008, 69 (06) : 957 - 962
  • [50] 131I thyroid cancer scans under the stimulation of thyrogen (TTCS) identifies iodine-avid lesions less effectively than post-ablation thyroid cancer scan (PTCS).
    Wong, FC
    Swantson, N
    Kim, EE
    Sherman, S
    Podoloff, DA
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 274P - 274P
12345